The president said that one of his daughters had tested the drug on herself.
- Developed by Moscow’s Gamaleya Research Institute of Epidemiology and Microbiology, the dose is based on a platform already used for six other vaccines, according to Russian Minister of Health Mikhail Murashko.
- The Ministry of Health registered ‘Sputnik V’ as a solution to be injected.
- According to the results of clinical studies, the vaccine has shown both high efficacy and safety.
- All the volunteers developed high titers [concentration levels] of antibodies to Covid-19, Murashko noted.
- He also said that “none of them had serious complications” after receiving the vaccine.
- After vaccination, immunity to Covid-19 can last up to two years, the Health Ministry claimed.
How will the vaccine be distributed?
- President Putin expects that mass production of the coronavirus vaccine will begin in the near future.
- The solution will be produced at two sites: The Russian Ministry of Health’s Gamaleya Institute and the domestic biopharmaceutical company Binnopharm.
- Some foreign countries have already shown interest in acquiring doses of the Russian vaccine.
- Medical workers and teachers will be the first to receive the vaccine.
- Vaccination of medical professionals could begin in late August or September.
- ‘Sputnik V’ will be available to the general public on January 1, 2021.
- Vaccination will be voluntary in Russia.
The Russian Direct Investment Fund and the Gamaleya Institute of Epidemiology and Microbiology have launched a new website with information about ‘Sputnik V’.